TY - JOUR
T1 - A profile of treatment approaches used at comprehensive cancer centers
AU - Laszlo, John
AU - Lenhard, Raymond
AU - Dahlberg, Steven
AU - Feigl, Polly
N1 - Funding Information:
Fred Hutchinson Cancer Research Center. Seattle. Washington (Supported by a contract from the National Cancer Institute-NOI-CO-75325) Project Head : Unit Heads:
PY - 1982
Y1 - 1982
N2 - The Centralized Cancer Patient Data System is the system which the 21 comprehensive cancer centers in the U.S. have established in order to report and to analyze demographic, diagnostic, treatment and survival data on all new patients. We propose that this closely monitored standardized 36 item dataset can be used to profile the categories of initial treatment that are given to patients having all types and stages of cancer: the data may be displayed for all centers or used to compare the approaches used at different centers. Differences in the frequency with which surgery, radiation, chemotherapy, and no specific treatment are used for patients having any of three commonh histologic types of lung cancer serve to illustrate the method. Opportunities now exist to utilize this new resource to study trends in the use of treatment modalities and their relationship to survival, which in turn should enhance the accessibility of treatment information about all patients at cancer centers, rather than only those which are reported from selected treatment protocols. This approach may also be uniquely useful in obtaining treatment and survival information about patients with rare sites or types of cancer.
AB - The Centralized Cancer Patient Data System is the system which the 21 comprehensive cancer centers in the U.S. have established in order to report and to analyze demographic, diagnostic, treatment and survival data on all new patients. We propose that this closely monitored standardized 36 item dataset can be used to profile the categories of initial treatment that are given to patients having all types and stages of cancer: the data may be displayed for all centers or used to compare the approaches used at different centers. Differences in the frequency with which surgery, radiation, chemotherapy, and no specific treatment are used for patients having any of three commonh histologic types of lung cancer serve to illustrate the method. Opportunities now exist to utilize this new resource to study trends in the use of treatment modalities and their relationship to survival, which in turn should enhance the accessibility of treatment information about all patients at cancer centers, rather than only those which are reported from selected treatment protocols. This approach may also be uniquely useful in obtaining treatment and survival information about patients with rare sites or types of cancer.
UR - http://www.scopus.com/inward/record.url?scp=0020425005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020425005&partnerID=8YFLogxK
U2 - 10.1016/0021-9681(82)90050-9
DO - 10.1016/0021-9681(82)90050-9
M3 - Article
C2 - 6292252
AN - SCOPUS:0020425005
SN - 0021-9681
VL - 35
SP - 853
EP - 859
JO - Journal of Chronic Diseases
JF - Journal of Chronic Diseases
IS - 11
ER -